Skip to main content
. Author manuscript; available in PMC: 2016 Jan 5.
Published in final edited form as: Menopause. 2014 Jun;21(6):612–623. doi: 10.1097/GME.0000000000000093

Figure 3B.

Figure 3B

Sexual Function Outcome Measures

In the bar graphs on the left, data represent absolute mean changes (± SE) from baseline for each treatment group. The * represents a significant difference between mean on treatment change in dose group vs. placebo at a 0.05 level; the significance level for the overall dose effect (by likelihood ratio test) is also shown. Scatterplots on the right display estimates and 95% confidence regions for the Generalized Additive Model (GAM) of change in sexual function outcomes as a function of free testosterone levels. The p−values displayed here are from a significance test of no association. SAL, Sexual Activity Log; FSDS, Female Sexual Distress Scale; PGWBI, Psychological General Well-Being Index